The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Abstract
The myelodysplastic syndromes (MDS) comprise a heterogenous group of myeloid disorders with a highly variable disease course. Diagnostic criteria to better stratify patients with MDS continue to evolve, based on morphology, cytogenetics, and the presence of cytopenias. More accurate classification of patients will allow for better treatment guidance. Treatment encompasses supportive care, treatment of anemia, low-intensity therapy, and high-intensity therapy. This portion of the guidelines focuses on diagnostic classification, molecular abnormalities, therapeutic options, and recommended treatment approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3835 · Cited by 3,267
Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663
Self-citationThe World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., Kantarjian, H., Raza, A., Levine, R. L., Neuberg, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013343 · Cited by 1,627
Self-citationCheson, B. D. (2006) · Blood · doi:10.1182/blood-2005-10-4149 · Cited by 1,580
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T., Nagata, Y., Grossmann, V, Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014) · Leukemia · doi:10.1038/leu.2013.336 · Cited by 1,532
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Self-citationAcute myeloid leukemia ontogeny is defined by distinct somatic mutations
Lindsley, R. C., Mar, B. G., Mazzola, E., Grauman, P. V., Shareef, S., Allen, S. L., Pigneux, A., Wetzler, M., Stuart, R. K., Erba, H. P., et al. (2015) · Blood · doi:10.1182/blood-2014-11-610543 · Cited by 991
Self-citationSchanz, J., Tüchler, H., Solé, F., Mallo, M., Luño, E., Cervera, J., Granada, I., Hildebrandt, B., Slovak, M. L., Ohyashiki, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6394 · Cited by 688
Self-citationKantarjian, H., Oki, Y., Garcia-Manero, G., Huang, X., O'Brien, S., Cortes, J., Faderl, S., Bueso-Ramos, C., Ravandi, F., Estrov, Z., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021162 · Cited by 685
Self-citationCheson, B. D., Bennett, J. M., Kantarjian, H. M., Pinto, A., Schiffer, C. A., Nimer, S. D., Löwenberg, B., Beran, M., de Witte, T. M., Stone, R. M., et al. (2000) · PubMed · Cited by 666
Self-citationRecurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Graubert, T. A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C. L., Shao, J., Krysiak, K., Harris, C. C., Koboldt, D. C., Larson, D. E., et al. (2012) · Nature Genetics · doi:10.1038/ng.1031 · Cited by 580
Self-citationWijermans, P., Lübbert, M., Verhoef, G., Bosly, A., Ravoet, C., Andre, M., & Ferrant, A. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.956 · Cited by 567
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Bejar, R., Lord, A., Stevenson, K., Bar-Natan, M., Pérez-Ladaga, A., Zaneveld, J., Wang, H., Caughey, B., Stojanov, P., Getz, G., et al. (2014) · Blood · doi:10.1182/blood-2014-06-582809 · Cited by 562
Self-citationSilverman, L. R., McKenzie, D. R., Peterson, B. L., Holland, J. F., Backstrom, J. T., Beach, C. L., & Larson, R. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4346 · Cited by 552
Lübbert, M., Suciu, S., Baila, L., Rüter, B. H., Platzbecker, U., Giagounidis, A., Selleslag, D., Labar, B., Germing, U., Salih, H. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.9245 · Cited by 552
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Itzykson, R., Kosmider, O., Renneville, A., Gelsi-Boyer, V., Meggendorfer, M., Morabito, M., Berthon, C., Adès, L., Fenaux, P., Beyne-Rauzy, O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3314 · Cited by 545
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
Walter, M. J., Ding, L., Shen, D., Shao, J., Grillot, M., McLellan, M., Fulton, R., Schmidt, H., Kalicki-Veizer, J., O'Laughlin, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.44 · Cited by 527
Self-citationValent, P., Horny, H.-P., Bennett, J. M., Fonatsch, C., Germing, U., Greenberg, P., Haferlach, T., Haase, D., Kolb, H.-J., Krieger, O., et al. (2007) · Leukemia Research · doi:10.1016/j.leukres.2006.11.009 · Cited by 513
Self-citationHorse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
Scheinberg, P., Nunez, O., Weinstein, B., Scheinberg, P., Biancotto, A., Wu, C. O., & Young, N. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103975 · Cited by 504
Malcovati, L., Papaemmanuil, E., Bowen, D. T., Boultwood, J., Della Porta, M. G., Pascutto, C., Travaglino, E., Groves, M. J., Godfrey, A. L., Ambaglio, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377275 · Cited by 498
McClune, B. L., Weisdorf, D. J., Pedersen, T. L., Tunes da Silva, G., Tallman, M. S., Sierra, J., DiPersio, J., Keating, A., Gale, R. P., George, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4821 · Cited by 487
Fenaux, P., Giagounidis, A., Selleslag, D., Beyne-Rauzy, O., Mufti, G., Mittelman, M., Muus, P., te Boekhorst, P., Sanz, G., del Cañizo, C., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330126 · Cited by 486
Hellström‐Lindberg, E., Gulbrandsen, N., Lindberg, G., Ahlgren, T., Dahl, I. M. S., Dybedal, I., Grimfors, G., Hesse‐Sundin, E., Hjorth, M., Kanter‐Lewensohn, L., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04153.x · Cited by 458
Bejar, R., Stevenson, K. E., Caughey, B. A., Abdel-Wahab, O., Steensma, D. P., Galili, N., Raza, A., Kantarjian, H., Levine, R. L., Neuberg, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7379 · Cited by 441
Self-citationRaza, A., Reeves, J. A., Feldman, E. J., Dewald, G. W., Bennett, J. M., Deeg, H. J., Dreisbach, L., Schiffer, C. A., Stone, R. M., Greenberg, P. L., et al. (2008) · Blood · doi:10.1182/blood-2007-01-068833 · Cited by 425
Self-citationThol, F., Kade, S., Schlarmann, C., Löffeld, P., Morgan, M., Krauter, J., Wlodarski, M. W., Kölking, B., Wichmann, M., Görlich, K., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399337 · Cited by 419
Kornblith, A. B., Herndon, J. E., Silverman, L. R., Demakos, E. P., Odchimar-Reissig, R., Holland, J. F., Powell, B. L., DeCastro, C., Ellerton, J., Larson, R. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.044 · Cited by 419
Self-citationRecurrent SETBP1 mutations in atypical chronic myeloid leukemia
Piazza, R., Valletta, S., Winkelmann, N., Redaelli, S., Spinelli, R., Pirola, A., Antolini, L., Mologni, L., Donadoni, C., Papaemmanuil, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2495 · Cited by 403
Park, S., Grabar, S., Kelaidi, C., Beyne-Rauzy, O., Picard, F., Bardet, V., Coiteux, V., Leroux, G., Lepelley, P., Daniel, M.-T., et al. (2008) · Blood · doi:10.1182/blood-2007-06-096370 · Cited by 334
Self-citationSorror, M. L., Sandmaier, B. M., Storer, B. E., Franke, G. N., Laport, G. G., Chauncey, T. R., Agura, E., Maziarz, R. T., Langston, A., Hari, P., et al. (2011) · JAMA · doi:10.1001/jama.2011.1558 · Cited by 320
Kwok, B., Hall, J. M., Witte, J. S., Xu, Y., Reddy, P., Lin, K., Flamholz, R., Dabbas, B., Yung, A., Al-Hafidh, J., et al. (2015) · Blood · doi:10.1182/blood-2015-08-667063 · Cited by 317
Self-citationHellström‐Lindberg, E., Negrin, R., Stein, R., Krantz, S., Lindberg, G., Vardiman, J., ÖSt, Å., & Greenberg, P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4013211.x · Cited by 312
Self-citationHellström-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., et al. (1998) · Blood · doi:10.1182/blood.v92.1.68.413k23_68_75 · Cited by 304
Alyea, E. P., Kim, H. T., Ho, V., Cutler, C., Gribben, J., DeAngelo, D. J., Lee, S. J., Windawi, S., Ritz, J., Stone, R. M., et al. (2005) · Blood · doi:10.1182/blood-2004-05-1947 · Cited by 300
Self-citationJädersten, M., Malcovati, L., Dybedal, I., Giovanni Della Porta, M., Invernizzi, R., Montgomery, S. M., Pascutto, C., Porwit, A., Cazzola, M., & Hellström-Lindberg, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4906 · Cited by 300
Germing, U., Gattermann, N., Strupp, C., Aivado, M., & Aul, C. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00088-6 · Cited by 296
Koreth, J., Pidala, J., Perez, W. S., Deeg, H. J., Garcia-Manero, G., Malcovati, L., Cazzola, M., Park, S., Itzykson, R., Ades, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8652 · Cited by 284
Self-citationPatnaik, M. M., Itzykson, R., Lasho, T. L., Kosmider, O., Finke, C. M., Hanson, C. A., Knudson, R. A., Ketterling, R. P., Tefferi, A., & Solary, E. (2014) · Leukemia · doi:10.1038/leu.2014.125 · Cited by 281
Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes
Dunn, D. E., Tanawattanacharoen, P., Boccuni, P., Nagakura, S., Green, S. W., Kirby, M. R., Kumar, M. S. A., Rosenfeld, S., & Young, N. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-6-199909210-00002 · Cited by 279
Sloand, E. M., Wu, C. O., Greenberg, P., Young, N., & Barrett, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9214 · Cited by 277
Self-citationAntithymocyte globulin for patients with myelodysplastic syndrome
Molldrem, J. J., Caples, M., Mavroudis, D., Plante, M., Young, N. S., & Barrett, A. J. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4423249.x · Cited by 275
Lyons, R. M., Cosgriff, T. M., Modi, S. S., Gersh, R. H., Hainsworth, J. D., Cohn, A. L., McIntyre, H. J., Fernando, I. J., Backstrom, J. T., & Beach, C. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1058 · Cited by 274
Saunthararajah, Y., Nakamura, R., Nam, J.-M., Robyn, J., Loberiza, F., Maciejewski, J. P., Simonis, T., Molldrem, J., Young, N. S., & Barrett, A. J. (2002) · Blood · doi:10.1182/blood.v100.5.1570.h81702001570_1570_1574 · Cited by 273
Somatic SETBP1 mutations in myeloid malignancies
Makishima, H., Yoshida, K., Nguyen, N., Przychodzen, B., Sanada, M., Okuno, Y., Ng, K. P., Gudmundsson, K. O., Vishwakarma, B. A., Jerez, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2696 · Cited by 257
Scott, B. L., Sandmaier, B. M., Storer, B., Maris, M. B., Sorror, M. L., Maloney, D. G., Chauncey, T. R., Storb, R., & Deeg, H. J. (2006) · Leukemia · doi:10.1038/sj.leu.2404010 · Cited by 235
Self-citationGreenberg, P. L., Lee, S. J., Advani, R., Tallman, M. S., Sikic, B. I., Letendre, L., Dugan, K., Lum, B., Chin, D. L., Dewald, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.048 · Cited by 235
Self-citationLubbert, M., Wijermans, P., Kunzmann, R., Verhoef, G., Bosly, A., Ravoet, C., Andre, M., & Ferrant, A. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02933.x · Cited by 224
Sakaguchi, H., Okuno, Y., Muramatsu, H., Yoshida, K., Shiraishi, Y., Takahashi, M., Kon, A., Sanada, M., Chiba, K., Tanaka, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2698 · Cited by 220
Santini, V., Almeida, A., Giagounidis, A., Gröpper, S., Jonasova, A., Vey, N., Mufti, G. J., Buckstein, R., Mittelman, M., Platzbecker, U., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.66.0118 · Cited by 215
Damaj, G., Duhamel, A., Robin, M., Beguin, Y., Michallet, M., Mohty, M., Vigouroux, S., Bories, P., Garnier, A., El Cheikh, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.3499 · Cited by 209
Wang, S. A., Hasserjian, R. P., Fox, P. S., Rogers, H. J., Geyer, J. T., Chabot-Richards, D., Weinzierl, E., Hatem, J., Jaso, J., Kanagal-Shamanna, R., et al. (2014) · Blood · doi:10.1182/blood-2014-02-553800 · Cited by 206
Alessandrino, E. P., Della Porta, M. G., Bacigalupo, A., Van Lint, M. T., Falda, M., Onida, F., Bernardi, M., Iori, A. P., Rambaldi, A., Cerretti, R., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143735 · Cited by 195
Silverman, L. R., Fenaux, P., Mufti, G. J., Santini, V., Hellström‐Lindberg, E., Gattermann, N., Sanz, G., List, A. F., Gore, S. D., & Seymour, J. F. (2011) · Cancer · doi:10.1002/cncr.25774 · Cited by 194
Passweg, J. R., Giagounidis, A. A. N., Simcock, M., Aul, C., Dobbelstein, C., Stadler, M., Ossenkoppele, G., Hofmann, W.-K., Schilling, K., Tichelli, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.2686 · Cited by 190
Meggendorfer, M., Bacher, U., Alpermann, T., Haferlach, C., Kern, W., Gambacorti-Passerini, C., Haferlach, T., & Schnittger, S. (2013) · Leukemia · doi:10.1038/leu.2013.133 · Cited by 181
Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression
Cargo, C. A., Rowbotham, N., Evans, P. A., Barrans, S. L., Bowen, D. T., Crouch, S., & Jack, A. S. (2015) · Blood · doi:10.1182/blood-2015-08-663237 · Cited by 178
Giagounidis, A., Mufti, G. J., Fenaux, P., Sekeres, M. A., Szer, J., Platzbecker, U., Kuendgen, A., Gaidano, G., Wiktor‐Jedrzejczak, W., Hu, K., et al. (2014) · Cancer · doi:10.1002/cncr.28663 · Cited by 175
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms
Cazzola, M., Rossi, M., & Malcovati, L. (2012) · Blood · doi:10.1182/blood-2012-09-399725 · Cited by 175
Gerds, A. T., Gooley, T. A., Estey, E. H., Appelbaum, F. R., Deeg, H. J., & Scott, B. L. (2012) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2012.01.009 · Cited by 175
Self-citationEstey, E. H., Thall, P. F., Cortes, J. E., Giles, F. J., O'Brien, S., Pierce, S. A., Wang, X., Kantarjian, H. M., & Beran, M. (2001) · Blood · doi:10.1182/blood.v98.13.3575 · Cited by 165
Nevill, T. J., Fung, H. C., Shepherd, J. D., Horsman, D. E., Nantel, S. H., Klingemann, H.-G., Forrest, D. L., Toze, C. L., Sutherland, H. J., Hogge, D. E., et al. (1998) · Blood · doi:10.1182/blood.v92.6.1910 · Cited by 161
Advani, R., Saba, H. I., Tallman, M. S., Rowe, J. M., Wiernik, P. H., Ramek, J., Dugan, K., Lum, B., Villena, J., Davis, E., et al. (1999) · Blood · doi:10.1182/blood.v93.3.787 · Cited by 158
Self-citationJerez, A., Clemente, M. J., Makishima, H., Rajala, H. L. M., Gómez‐Seguí, I., Olson, T. L., McGraw, K. L., Przychodzen, B. P., Kulasekararaj, A. G., Afable, M. G., et al. (2013) · Blood · doi:10.1182/blood-2013-04-494930 · Cited by 157
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing, U., Strupp, C., Kuendgen, A., Isa, S., Knipp, S., Hildebrandt, B., Giagounidis, A. A. N., Aul, C., Gattermann, N., & Haas, R. R. (2006) · PubMed · Cited by 154
Stadler, M., Germing, U., Kliche, K. O., Josten, K., Kuse, R., Hofmann, W.-K., Schrezenmeier, H., Novotný, J., Anders, O., Eimermacher, H., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403239 · Cited by 138
Gore, S. D., Fenaux, P., Santini, V., Bennett, J. M., Silverman, L. R., Seymour, J. F., Hellström‐Lindberg, E., Swern, A. S., Beach, C. L., & List, A. F. (2013) · Haematologica · doi:10.3324/haematol.2012.074831 · Cited by 135
Self-citation5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation
Field, T. L., Perkins, J. B., Huang, Y., Kharfan‐Dabaja, M. A., Alsina, M., Ayala, E., Fernandez, H. F., Janssen, W. E., Lancet, J. E., Perez, L. E., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.134 · Cited by 129
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
Gambacorti-Passerini, C. B., Donadoni, C., Parmiani, A., Pirola, A., Redaelli, S., Signore, G., Piazza, V., Malcovati, L., Fontana, D., Spinelli, R., et al. (2014) · Blood · doi:10.1182/blood-2014-06-579466 · Cited by 129
Myelodysplastic syndrome is not merely “preleukemia”
Albitar, M. X., Manshouri, T., Shen, Y., Liu, D., Beran, M., Kantarjian, H. M., Rogers, A. M., Jilani, I. B., Lin, C., Pierce, S. A., et al. (2002) · Blood · doi:10.1182/blood.v100.3.791 · Cited by 129
Ablative Allogeneic Hematopoietic Cell Transplantation in Adults 60 Years of Age and Older
Wallen, H. D., Gooley, T. A., Deeg, H. J., Pagel, J. M., Press, O. W., Appelbaum, F. R., Storb, R. F., & Gopal, A. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.694 · Cited by 127
Self-citationGerming, U., Lauseker, M., Hildebrandt, B., Symeonidis, A. S., Čermák, J., Fenaux, P., Kelaïdi, C., Pfeilstöcker, M., Nösslinger, T., Sekeres, M. A., et al. (2012) · Leukemia · doi:10.1038/leu.2011.391 · Cited by 126
Toma, A., Kosmider, O., Chevret, S., Delaunay, J., Stamatoullas, A., Rosé, C., Beyne‐Rauzy, O., Baños, A., Guerci‐Bresler, A., Wickenhauser, S., et al. (2015) · Leukemia · doi:10.1038/leu.2015.296 · Cited by 126
Mallo, M., Cervera, J., Schanz, J., Such, E., Garcia‐Manero, G., Luño, E., Steidl, C., Espinet, B., Vallespı́, T., Germing, U., et al. (2010) · Leukemia · doi:10.1038/leu.2010.231 · Cited by 121
Self-citationSeymour, J. F., Fenaux, P., Silverman, L. R., Mufti, G. J., Hellström‐Lindberg, E., Santini, V., List, A. F., Gore, S. D., Backstrom, J. T., McKenzie, D., et al. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.04.005 · Cited by 117
Kantarjian, H. M., O'Brien, S. M., Shan, J., Aribi, A. M., Garcia‐Manero, G., Jabbour, E. J., Ravandi, F., Cortes, J. E., Davisson, J., & Issa, J. J. (2006) · Cancer · doi:10.1002/cncr.22376 · Cited by 115
Self-citationJädersten, M., Saft, L., Pellagatti, A., Göhring, G., Wainscoat, J. S., Boultwood, J., Porwit‐MacDonald, A., Schlegelberger, B., & Hellström‐Lindberg, E. (2009) · Haematologica · doi:10.3324/haematol.2009.011528 · Cited by 101
Mannone, L., Gardin, C., Quarré, M. C., Bernard, J. F., Vassilieff, D., Adès, L., Park, S., Vaultier, S., Hamza, F., Beyne‐rauzy, M. O., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06070.x · Cited by 100
Stasi, R., Abruzzese, E., Lanzetta, G., Terzoli, E., & Amadori, S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi400 · Cited by 96
Darbepoetin alpha for the treatment of anaemia in low‐intermediate risk myelodysplastic syndromes
Musto, P., Lanza, F., Balleari, E., Grossi, A., Falcone, A. P., Sanpaolo, G., Bodenizza, C., Scalzulli, P. R., Sala, A. L., Campioni, D., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05288.x · Cited by 95
Mallo, M., Rey, M. D., Ibáñez, M., Calasanz, M. J., Arenillas, L., Larráyoz, M. J., Pedro, C., Jerez, A., Maciejewski, J. P., Costa, D., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12354 · Cited by 90
van den Bosch, J., Lübbert, M., Verhoef, G. E. G., & Wijermans, P. (2004) · Leukemia Research · doi:10.1016/j.leukres.2003.11.016 · Cited by 88
Oliansky, D. M., Antin, J. H., Bennett, J. M., Deeg, H. J., Engelhardt, C., Heptinstall, K. V., Lima, M. J. G. D., Gore, S. D., Potts, R. G., Silverman, L. R., et al. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.12.003 · Cited by 84
Self-citationon behalf of the International Working Group on MDS with del(5q), Kuendgen, A., Lauseker, M., List, A. F., Fenaux, P., Giagounidis, A. A. N., Brandenburg, N. A., Backstrom, J. T., Glasmacher, A., Hasford, J., et al. (2012) · Leukemia · doi:10.1038/leu.2012.369 · Cited by 81
Platzbecker, U., Wong, R. S. M., Verma, A. K., Abboud, C. N., Araujo, S., Chiou, T.-J., Feigert, J. M., Yeh, S., Götze, K. S. S., Gorin, N. C., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00149-0 · Cited by 81
Self-citationAllogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia
Kerbauy, D. M. B., Chyou, F., Gooley, T. A., Sorror, M. L., Scott, B. L., Pagel, J. M., Myerson, D., Appelbaum, F. R., Storb, R. F., & Deeg, H. J. (2005) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2005.05.008 · Cited by 76
Self-citationKelaïdi, C., Park, S., Bréchignac, S., Mannone, L., Vey, N., Dombret, H., Aljassem, L., Stamatoullas, A., Adès, L., Giraudier, S., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.11.037 · Cited by 76
Problematic WHO Reclassification of Myelodysplastic Syndromes
Members of the International MDS Study Group, & Head, D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3447 · Cited by 75
Self-citationFili, C. C., Malagola, M., Follo, M. Y., Finelli, C., Iacobucci, I., Martinelli, G., Cattina, F., Clissa, C., Candoni, A., Fanin, R., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3540 · Cited by 69
Jurado, M., Deeg, H. J., Storer, B. E., Anasetti, C., Anderson, J. E., Bryant, E. M., Chauncey, T. R., Doney, K., Flowers, M. E. D., Hansen, J. A., et al. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.pm11939606 · Cited by 68
Self-citationTaskesen, E., Havermans, M., van Lom, K., Sanders, M. A., van Norden, Y., Bindels, E. M., Hoogenboezem, R. M., Reinders, M. J. T., Figueroa, M. E., Valk, P. J. M., et al. (2014) · Blood · doi:10.1182/blood-2013-07-512855 · Cited by 62
Malcovati, L., Porta, M. G. D., Pascutto, C., Malabarba, L., Travaglino, E., Passamonti, F., Invernizzi, R., Lazzarino, M., & Cazzola, M. (2004) · Blood · doi:10.1182/blood.v104.11.1430.1430 · Cited by 61
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes
Greenberg, P. L., Tuechler, H., Schanz, J., Sanz, G. F., Garcia‐Manero, G., Solé, F. G., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., et al. (2016) · Blood · doi:10.1182/blood-2016-07-728766 · Cited by 51
Self-citationKelaïdi, C., Beyne‐Rauzy, O., Braun, T., Sapena, R., Cougoul, P., Adès, L., Pillard, F., Lambert, C., Charniot, J.-C., Guerci‐Bresler, A., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1686-4 · Cited by 46
Bokhari, S. W. I., Watson, L., Nagra, S., Cook, M. A., Byrne, J., Craddock, C., & Russell, N. H. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.138 · Cited by 43
Olíva, E. N., Latagliata, R., Laganà, C., Breccia, M., Galimberti, S., Morabito, F., Poloni, A., Balleari, E., Cortelezzi, A., Palumbo, G. A., et al. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.778406 · Cited by 30
[Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes].
Miyazaki, Y. (2013) · PubMed · Cited by 23
Wattel, E., Solary, É., Hecquet, B., Caillot, D., Ifrah, N., Brion, A., Milpied, N. J., Janvier, M., Guerci‐Bresler, A., Rochant, H., et al. (1999) · Cited by 15
Cited by
Next-generation sequencing and its clinical application
Dahui, Q. (2019) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2018.0055 · Cited by 333
Personalized prediction model to risk stratify patients with myelodysplastic syndromes
Nazha, A., Komrokji, R., Meggendorfer, M., Jia, X., Radakovich, N., Shreve, J., Hilton, C. B., Nagata, Y., Hamilton, B. K., Mukherjee, S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02810 · Cited by 169
Self-citationAdès, L., Girshova, L., Doronin, V. A., Díez-Campelo, M., Valcárcel, D., Kambhampati, S., Viniou, N.-A., Woszczyk, D., De Paz Arias, R., Symeonidis, A., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007334 · Cited by 130
Gondek, L. P., & DeZern, A. E. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30211-x · Cited by 63
Self-citation
Metadata
- Authors
- Greenberg, P. L., Stone, R. M., Al-Kali, A., Barta, S. K., Bejar, R., Bennett, J. M., Carraway, H., De Castro, C. M., Deeg, H. J., DeZern, A. E., Fathi, A. T., Frankfurt, O., Gaensler, K., Garcia-Manero, G., Griffiths, E. A., Head, D., Horsfall, R., Johnson, R. A., Juckett, M., Klimek, V. M., Komrokji, R., Kujawski, L. A., Maness, L. J., O'Donnell, M. R., Pollyea, D. A., Shami, P. J., Stein, B. L., Walker, A. R., Westervelt, P., Zeidan, A., Shead, D. A., & Smith, C.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2016-12-31
- Volume
- 15
- Issue
- 1
- Pages
- 60-87
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2583113562
- Cited by
- 297
- References
- 104
- FWCI
- 31.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.